title: Neonatal maintenance solution--is neonatalyte safe?
abstract: Newborns in the neonatal unit at Ga-Rankuwa Hospital who required intravenous fluids were randomly allocated, after 24 hours of life, to receive either Neonatalyte (Sabax) or a control solution. Biochemical monitoring was performed every 12 hours for a period of 5 days. Neonatalyte does not cause hyperkalaemia or hypocalcaemia in the early neonatal period.
authors: Department of Paediatrics, Medical University of Southern Africa, Pretoria.
authors: J B
authors: JB
authors: Ellis
authors: C C
authors: CC
authors: Lombard
authors: H F
authors: HF
authors: Joubert
authors: C A
authors: CA
authors: van der Merwe
authors: L
authors: L
authors: Hugo
mesh_terms: D002118:Calcium / Q000008:administration & dosage* / Q000097:blood; D004341:Drug Evaluation; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007262:Infusions, Intravenous / Q000592:standards*; D011188:Potassium / Q000008:administration & dosage* / Q000097:blood; D011897:Random Allocation
chemical_list: D011188:Potassium; D002118:Calcium